RL
Robert Lentz
Physician · BLUEMARK LLCOFFICE ALLY
Credentials: · · · · ·
History
- Present
BLUEMARK LLCOFFICE ALLY
- 2019–2021
Medical Oncology
Research
Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies
Journal of Surgical Oncology · 2019 · First of 3 authors · 281 citations
Innate Immune Checkpoint Inhibitors: The Next Breakthrough in Medical Oncology?
Review · Molecular Cancer Therapeutics · 2021 · First of 4 authors · 106 citations
The Diagnostic and Prognostic Value of Echocardiographic Strain
Review · JAMA Cardiology · 2019 · 50 citations
12 papers
10 papers
6 papers
4 papers · 4 as a fellow
4 papers · 4 as a fellow
4 papers
4 papers
3 papers
